Characterization of features and outcomes of young patients (< 45 years) presenting with ST-segment elevation myocardial infarction

The Egyptian Heart Journal

Table 3 Relationship between adverse clinical outcomes and age

	Age group		p-value
	≤ 45 years (n = 98)	> 45 years (n = 394)	p-value
Heart failure	18 (18.4%)	137 (34.8%)	0.002
Repeated hospital admission	7 (7.1%)	45 (11.4%)	0.218
Stent failure	2 (2%)	3 (0.8%)	0.204
New revascularization	7 (7.1%)	47 (11.9%)	0.175
Stroke	1 (1%)	5 (1.3%)	0.657
Recurrent MI	5 (5.1%)	16 (4.1%)	0.648
Death	3 (3.1%)	16 (4.1%)	0.646
MACE	10 (10.2%)	94 (23.9%)	0.003
Any adverse outcome	37 (37.8%)	225 (57.1%)	0.001
Effort intolerance	28 (28.6%)	170 (43.1%)	0.008

Bold values statistical significance, when p value is <0.05
MACE = Major adverse cardiovascular events (defined as all cause death; MI or target vessel revascularization), MI = Myocardial infarction